The AHA/CDC statement makes the following recommendations for the use of hs-CRP in clinical practice: In terms of the clinical chemistry of the assay, hs-CRP is the marker of choice. Results of ...

A scientific statement regarding CPET interpretation in patients with congenital HD across their lifespan has been published by the AHA.